Skip to main content
Erschienen in: Tumor Biology 6/2015

01.06.2015 | Research Article

MiR-511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3

verfasst von: Gang Cao, Weihua Dong, Xiaoxi Meng, Hongchao Liu, Huaqiang Liao, Shiyuan Liu

Erschienen in: Tumor Biology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

MicroRNAs (miRNAs) are critical for cancer development and progression. Elucidating the underlying mechanism of miRNAs in carcinogenesis may lead to novel diagnostic and therapeutic strategies for malignancy. In this study, we found that miR-511 expression was markedly downregulated in hepatocellular carcinoma (HCC) cell lines and tissues. Phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3) was identified as a direct target of miR-511 and miR-511 expression inversely correlated with PIK3R3 mRNA expression in clinical HCC tissues. We further demonstrated that miR-511 suppressed HCC cell proliferation, migration, and invasion by repressing PIK3R3 expression. Investigations of possible mechanisms underlying these results revealed that miR-511 inhibited the phosphorylation of AKT and mTOR, which are key participants in the AKT/mTOR pathway. Taken together, our findings provide new insights into tumor suppression by miR-511 by negatively regulating the PIK3R3/AKT/mTOR signaling pathway.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
Zurück zum Zitat Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg. 2009;249:118–23.CrossRefPubMed Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg. 2009;249:118–23.CrossRefPubMed
3.
Zurück zum Zitat Bartel DP. Micrornas: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.CrossRefPubMed Bartel DP. Micrornas: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.CrossRefPubMed
4.
Zurück zum Zitat Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10:126–39.CrossRefPubMed Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10:126–39.CrossRefPubMed
6.
Zurück zum Zitat Wiemer EA. The role of microRNAs in cancer: no small matter. Eur J Cancer. 2007;43:1529–44.CrossRefPubMed Wiemer EA. The role of microRNAs in cancer: no small matter. Eur J Cancer. 2007;43:1529–44.CrossRefPubMed
7.
Zurück zum Zitat Shen G, Rong X, Zhao J, Yang X, Li H, Jiang H, Zhou Q, Ji T, Huang S, Zhang J, Jia H. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma. Carcinogenesis 2014. Shen G, Rong X, Zhao J, Yang X, Li H, Jiang H, Zhou Q, Ji T, Huang S, Zhang J, Jia H. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma. Carcinogenesis 2014.
8.
Zurück zum Zitat Li L, Liu Y, Guo Y, Liu B, Zhao Y, Li P, Song F, Zheng H, Yu J, Song T, Niu R, Li Q, Wang XW, Zhang W, Chen K. Regulatory mir-148a-acvr1/bmp circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma. Hepatology 2014. Li L, Liu Y, Guo Y, Liu B, Zhao Y, Li P, Song F, Zheng H, Yu J, Song T, Niu R, Li Q, Wang XW, Zhang W, Chen K. Regulatory mir-148a-acvr1/bmp circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma. Hepatology 2014.
9.
Zurück zum Zitat Xiao Z, Li CH, Chan SL, Xu F, Feng L, Wang Y, Jiang JD, Sung JJ, Cheng CH, Chen Y. A small molecule modulator of the tumor suppressor miRNA-34a inhibits the growth of hepatocellular carcinoma. Cancer Res 2014. Xiao Z, Li CH, Chan SL, Xu F, Feng L, Wang Y, Jiang JD, Sung JJ, Cheng CH, Chen Y. A small molecule modulator of the tumor suppressor miRNA-34a inhibits the growth of hepatocellular carcinoma. Cancer Res 2014.
10.
Zurück zum Zitat Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB, et al. Hepatitis b virus × protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Eur J Cancer. 2014;50:2560–9.CrossRefPubMed Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB, et al. Hepatitis b virus × protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Eur J Cancer. 2014;50:2560–9.CrossRefPubMed
11.
Zurück zum Zitat Ge YY, Shi Q, Zheng ZY, Gong J, Zeng C, Yang J, et al. MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mtor and igf-1r. Oncotarget. 2014;5:6218–28.CrossRefPubMedPubMedCentral Ge YY, Shi Q, Zheng ZY, Gong J, Zeng C, Yang J, et al. MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mtor and igf-1r. Oncotarget. 2014;5:6218–28.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Liu Z, Tu K, Liu Q. Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma. FEBS Lett. 2014;588:3089–97.CrossRefPubMed Liu Z, Tu K, Liu Q. Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma. FEBS Lett. 2014;588:3089–97.CrossRefPubMed
13.
Zurück zum Zitat Wang J, Li J, Shen J, Wang C, Yang L, Zhang X. MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer. 2012;12:227.CrossRefPubMedPubMedCentral Wang J, Li J, Shen J, Wang C, Yang L, Zhang X. MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer. 2012;12:227.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Yuan Q, Loya K, Rani B, Mobus S, Balakrishnan A, Lamle J, et al. MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology. 2013;57:299–310.CrossRefPubMed Yuan Q, Loya K, Rani B, Mobus S, Balakrishnan A, Lamle J, et al. MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology. 2013;57:299–310.CrossRefPubMed
15.
Zurück zum Zitat Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest. 2012;122:2884–97.CrossRefPubMedPubMedCentral Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest. 2012;122:2884–97.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Zhang C, Chi YL, Wang PY, Wang YQ, Zhang YX, Deng J, et al. Mir-511 and mir-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene trib2. PLoS ONE. 2012;7:e46090.CrossRefPubMedPubMedCentral Zhang C, Chi YL, Wang PY, Wang YQ, Zhang YX, Deng J, et al. Mir-511 and mir-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene trib2. PLoS ONE. 2012;7:e46090.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Kim TH, Kim YK, Kwon Y, Heo JH, Kang H, Kim G, et al. Deregulation of mir-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology. 2010;57:734–43.CrossRefPubMed Kim TH, Kim YK, Kwon Y, Heo JH, Kang H, Kim G, et al. Deregulation of mir-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology. 2010;57:734–43.CrossRefPubMed
18.
Zurück zum Zitat Tombol Z, Szabo PM, Molnar V, Wiener Z, Tolgyesi G, Horanyi J, et al. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr Relat Cancer. 2009;16:895–906.CrossRefPubMed Tombol Z, Szabo PM, Molnar V, Wiener Z, Tolgyesi G, Horanyi J, et al. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr Relat Cancer. 2009;16:895–906.CrossRefPubMed
19.
Zurück zum Zitat Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT. Mir-138 induces cell cycle arrest by targeting cyclin d3 in hepatocellular carcinoma. Carcinogenesis. 2012;33:1113–20.CrossRefPubMedPubMedCentral Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT. Mir-138 induces cell cycle arrest by targeting cyclin d3 in hepatocellular carcinoma. Carcinogenesis. 2012;33:1113–20.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Wang H, An H, Wang B, Liao Q, Li W, Jin X, et al. Mir-133a represses tumour growth and metastasis in colorectal cancer by targeting lim and sh3 protein 1 and inhibiting the mapk pathway. Eur J Cancer. 2013;49:3924–35.CrossRefPubMed Wang H, An H, Wang B, Liao Q, Li W, Jin X, et al. Mir-133a represses tumour growth and metastasis in colorectal cancer by targeting lim and sh3 protein 1 and inhibiting the mapk pathway. Eur J Cancer. 2013;49:3924–35.CrossRefPubMed
21.
Zurück zum Zitat Chang RM, Yang H, Fang F, Xu JF, Yang LY. Microrna-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting ph domain and leucine-rich repeat protein phosphatase. Hepatology. 2014;60:1251–63.CrossRefPubMed Chang RM, Yang H, Fang F, Xu JF, Yang LY. Microrna-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting ph domain and leucine-rich repeat protein phosphatase. Hepatology. 2014;60:1251–63.CrossRefPubMed
22.
Zurück zum Zitat Xu L, Wen Z, Zhou Y, Liu Z, Li Q, Fei G, et al. Microrna-7-regulated tlr9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/akt pathway. Mol Biol Cell. 2013;24:42–55.CrossRefPubMedPubMedCentral Xu L, Wen Z, Zhou Y, Liu Z, Li Q, Fei G, et al. Microrna-7-regulated tlr9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/akt pathway. Mol Biol Cell. 2013;24:42–55.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Augello C, Gianelli U, Savi F, Moro A, Bonoldi E, Gambacorta M, et al. Microrna as potential biomarker in hcv-associated diffuse large B-cell lymphoma. J Clin Pathol. 2014;67:697–701.CrossRefPubMed Augello C, Gianelli U, Savi F, Moro A, Bonoldi E, Gambacorta M, et al. Microrna as potential biomarker in hcv-associated diffuse large B-cell lymphoma. J Clin Pathol. 2014;67:697–701.CrossRefPubMed
24.
Zurück zum Zitat Tserel L, Runnel T, Kisand K, Pihlap M, Bakhoff L, Kolde R, et al. MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal mir-511 as putative positive regulator of toll-like receptor 4. J Biol Chem. 2011;286:26487–95.CrossRefPubMedPubMedCentral Tserel L, Runnel T, Kisand K, Pihlap M, Bakhoff L, Kolde R, et al. MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal mir-511 as putative positive regulator of toll-like receptor 4. J Biol Chem. 2011;286:26487–95.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Zhang L, Huang J, Yang N, Greshock J, Liang S, Hasegawa K, et al. Integrative genomic analysis of phosphatidylinositol 3′-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer. Clin Cancer Res. 2007;13:5314–21.CrossRefPubMed Zhang L, Huang J, Yang N, Greshock J, Liang S, Hasegawa K, et al. Integrative genomic analysis of phosphatidylinositol 3′-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer. Clin Cancer Res. 2007;13:5314–21.CrossRefPubMed
26.
Zurück zum Zitat Soroceanu L, Kharbanda S, Chen R, Soriano RH, Aldape K, Misra A, et al. Identification of igf2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma. Proc Natl Acad Sci U S A. 2007;104:3466–71.CrossRefPubMedPubMedCentral Soroceanu L, Kharbanda S, Chen R, Soriano RH, Aldape K, Misra A, et al. Identification of igf2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma. Proc Natl Acad Sci U S A. 2007;104:3466–71.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Zhou J, Chen GB, Tang YC, Sinha RA, Wu Y, Yap CS, et al. Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library. BMC Med Genom. 2012;5:34.CrossRef Zhou J, Chen GB, Tang YC, Sinha RA, Wu Y, Yap CS, et al. Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library. BMC Med Genom. 2012;5:34.CrossRef
28.
Zurück zum Zitat Wang G, Yang X, Li C, Cao X, Luo X, Hu J. PIK3R3 induces epithelial-to-mesenchymal transition and promotes metastasis in colorectal cancer. Mol Cancer Ther. 2014;13:1837–47.CrossRefPubMed Wang G, Yang X, Li C, Cao X, Luo X, Hu J. PIK3R3 induces epithelial-to-mesenchymal transition and promotes metastasis in colorectal cancer. Mol Cancer Ther. 2014;13:1837–47.CrossRefPubMed
29.
Zurück zum Zitat Klahan S, Wu MS, Hsi E, Huang CC, Hou MF, Chang WC. Computational analysis of mRNA expression profiles identifies the ITG family and PIK3R3 as crucial genes for regulating triple negative breast cancer cell migration. Biomed Res Int. 2014;2014:536591.CrossRefPubMedPubMedCentral Klahan S, Wu MS, Hsi E, Huang CC, Hou MF, Chang WC. Computational analysis of mRNA expression profiles identifies the ITG family and PIK3R3 as crucial genes for regulating triple negative breast cancer cell migration. Biomed Res Int. 2014;2014:536591.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Wu DM, Zhang P, Liu RY, Sang YX, Zhou C, Xu GC, et al. Phosphorylation and changes in the distribution of nucleolin promote tumor metastasis via the PI3K/AKT pathway in colorectal carcinoma. FEBS Lett. 2014;588:1921–9.CrossRefPubMed Wu DM, Zhang P, Liu RY, Sang YX, Zhou C, Xu GC, et al. Phosphorylation and changes in the distribution of nucleolin promote tumor metastasis via the PI3K/AKT pathway in colorectal carcinoma. FEBS Lett. 2014;588:1921–9.CrossRefPubMed
31.
Zurück zum Zitat Yu T, Li J, Yan M, Liu L, Lin H, Zhao F, Sun L, Zhang Y, Cui Y, Zhang F, He X, Yao M. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway. Oncogene 2014. Yu T, Li J, Yan M, Liu L, Lin H, Zhao F, Sun L, Zhang Y, Cui Y, Zhang F, He X, Yao M. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway. Oncogene 2014.
Metadaten
Titel
MiR-511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3
verfasst von
Gang Cao
Weihua Dong
Xiaoxi Meng
Hongchao Liu
Huaqiang Liao
Shiyuan Liu
Publikationsdatum
01.06.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 6/2015
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3085-z

Weitere Artikel der Ausgabe 6/2015

Tumor Biology 6/2015 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.